2008年，日本第三大医药公司Daiichi Sankyo购买了印度的仿制药品生产商Ranbaxy，一定程度上使药品国产化。

In 2008 Daiichi Sankyo, Japan's third-biggest drug company, bought Ranbaxy, an Indian generics-maker, in part to bring the drugs home.

youdao

替伐普坦制造商，日本大冢制药有限公司负责本研究费用，Konstam是该研究顾问之一。

Tolvaptan's maker, Otsuka Pharmaceutical Co. of Japan, paid for the study and Konstam is one of its consultants.

youdao